— Know what they know.
Not Investment Advice

EYPT NASDAQ

EyePoint Pharmaceuticals, Inc.
1W: -3.5% 1M: -10.2% 3M: -16.6% YTD: -26.9% 1Y: +105.8% 3Y: +115.2% 5Y: +44.1%
$12.93
+0.15 (+1.17%)
 
Weekly Expected Move ±6.4%
$11 $12 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 32 · $1.1B mcap · 75M float · 1.43% daily turnover · Short 72% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
31.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -1070.4%  ·  5Y Avg: -1523.6%
Cost Advantage
38
Intangibles
34
Switching Cost
24
Network Effect
43
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EYPT has No discernible competitive edge (31.9/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -1070.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$34
Avg Target
$34
High
Based on 4 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$34.00
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-19 Mizuho Securities $33 $36 +3 +150.7% $14.36
2026-02-05 RBC Capital Lisa Walter Initiated $39 +195.0% $13.22
2025-10-29 Mizuho Securities Graig Suvannavejh $28 $33 +5 +169.4% $12.25
2025-10-20 Mizuho Securities Graig Suvannavejh $30 $28 -2 +140.8% $11.63
2024-11-11 H.C. Wainwright Yi Chen $30 $22 -8 +89.9% $11.59
2024-05-13 H.C. Wainwright Yi Chen $25 $30 +5 +146.5% $12.17
2024-05-07 Mizuho Securities Graig Suvannavejh Initiated $30 +167.9% $11.20
2022-08-04 H.C. Wainwright Initiated $25 +144.6% $10.22

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EYPT receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-03-05 D+ C-
2026-03-04 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

26 Grade D
Profitability
7
Balance Sheet
84
Earnings Quality
72
Growth
12
Value
37
Momentum
20
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. EYPT scores highest in Safety (100/100) and lowest in Profitability (7/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.69
Safe Zone
Piotroski F-Score
2/9
Beneish M-Score
26.20
Possible Manipulator
Ohlson O-Score
1.15
Bankruptcy prob: 75.9%
High Risk
Credit Rating
A+
Score: 75.6/100
Trend: Improving
Earnings Quality
OCF/NI: 0.99x
Accruals: -1.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EYPT scores 5.69, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EYPT scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. EYPT's score of 26.20 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EYPT's implied 75.9% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EYPT receives an estimated rating of A+ (score: 75.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-4.09x
PEG
0.12x
P/S
142.36x
P/B
4.82x
P/FCF
-4.08x
P/OCF
EV/EBITDA
-2.96x
EV/Revenue
108.10x
EV/EBIT
-2.94x
EV/FCF
-3.03x
Earnings Yield
-24.50%
FCF Yield
-24.50%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. EYPT currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.001
NI / EBT
×
Interest Burden
0.971
EBT / EBIT
×
EBIT Margin
-36.708
EBIT / Rev
×
Asset Turnover
0.019
Rev / Assets
×
Equity Multiplier
1.218
Assets / Equity
=
ROE
-84.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EYPT's ROE of -84.5% is driven by Asset Turnover (0.019), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$12.93
Median 1Y
$7.56
5th Pctile
$1.69
95th Pctile
$34.01
Ann. Volatility
96.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jay Duker
President and Chief Executive Officer
$696,251 $1,610,700 $5,568,352
George Elston Financial
Vice President and Chief Financial Officer
$527,677 $487,340 $2,173,376
Ramiro Ribeiro Medical
edical Officer
$505,007 $487,340 $2,157,130

CEO Pay Ratio

23:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,568,352
Avg Employee Cost (SGA/emp): $241,589
Employees: 214

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
214
+29.7% YoY
Revenue / Employee
$146,593
Rev: $31,371,000
Profit / Employee
$-1,083,935
NI: $-231,962,000
SGA / Employee
$241,589
Avg labor cost proxy
R&D / Employee
$1,032,893
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -3.1% -4.1% -57.6% -66.1% -75.4% -77.1% -72.8% -73.0% -75.5% -71.3% -39.0% -43.5% -47.9% -57.1% -43.4% -48.7% -58.2% -68.3% -72.2% -84.5% -84.53%
ROA -50.5% -66.1% -32.9% -37.8% -43.1% -44.1% -46.1% -46.2% -47.8% -45.1% -26.4% -29.5% -32.4% -38.7% -33.8% -37.9% -45.3% -53.2% -59.3% -69.4% -69.42%
ROIC -2.0% -2.7% -3.6% -4.1% -4.7% -4.9% 42.7% 44.1% 45.6% 43.9% 99.1% 1.1% 1.3% 1.5% 9.2% 10.2% 11.9% 13.7% -9.2% -10.7% -10.70%
ROCE -45.8% -63.1% -22.1% -25.8% -30.0% -31.1% -67.9% -68.3% -70.8% -67.3% -23.8% -26.9% -29.7% -35.5% -35.4% -40.7% -49.2% -57.4% -73.7% -85.5% -85.49%
Gross Margin 78.6% 79.9% 73.7% 80.9% 85.0% 86.0% 67.6% 91.7% 80.3% 92.1% 92.9% 93.5% 85.2% 93.0% 93.0% 96.7% 96.9% 25.4% 39.5% 24.1% 24.14%
Operating Margin -1.2% -1.7% -1.6% -2.0% -1.7% -1.8% -4.2% -2.8% -2.5% -94.7% -1.2% -2.9% -3.6% -3.1% -3.9% -2.0% -11.7% -64.2% -113.5% -125.3% -125.32%
Net Margin -1.1% -1.8% -1.7% -2.3% -1.7% -1.8% -4.1% -2.8% -2.5% -83.0% -1.0% -2.5% -3.3% -2.8% -3.6% -1.8% -11.1% -61.8% -109.0% -121.9% -121.89%
EBITDA Margin -88.2% -1.6% -1.5% -2.1% -1.6% -1.7% -4.0% -2.6% -2.5% -82.2% -99.1% -2.5% -3.2% -2.8% -3.5% -2.0% -11.6% -61.2% -113.5% -125.3% -125.32%
FCF Margin -48.4% -85.7% -1.4% -1.4% -1.5% -1.7% -1.6% -1.6% 31.6% 21.7% -3.5% -33.3% -1.9% -2.6% -3.0% -2.7% -3.7% -5.0% -7.8% -35.7% -35.66%
OCF Margin -47.5% -84.7% -1.4% -1.4% -1.5% -1.6% -1.6% -1.6% 38.7% 29.2% 4.1% -24.9% -1.8% -2.5% -2.9% -2.6% -3.7% -5.0% -7.7% -35.1% -35.13%
ROE 3Y Avg snapshot only -53.99%
ROE 5Y Avg snapshot only -60.94%
ROA 3Y Avg snapshot only -43.97%
ROIC 3Y Avg snapshot only -21.19%
ROIC Economic snapshot only -68.14%
Cash ROA snapshot only -73.50%
Cash ROIC snapshot only -12.86%
CROIC snapshot only -13.06%
NOPAT Margin snapshot only -29.24%
Pretax Margin snapshot only -35.64%
R&D / Revenue snapshot only 30.81%
SGA / Revenue snapshot only 6.96%
SBC / Revenue snapshot only 2.63%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -6.22 -5.50 -6.85 -6.74 -3.84 -3.78 -1.28 -1.08 -3.09 -3.06 -13.77 -13.86 -5.33 -4.20 -3.67 -2.58 -3.75 -4.86 -6.54 -4.08 -4.094
P/S Ratio 6.60 9.22 10.84 11.63 7.08 6.96 3.16 2.77 8.76 7.20 21.18 21.87 9.19 9.52 11.11 6.75 12.68 23.60 48.35 145.57 142.360
P/B Ratio 13.94 16.17 2.17 2.45 1.59 1.60 1.36 1.14 3.39 3.18 3.66 4.11 1.74 1.63 1.43 1.12 1.96 2.97 4.96 3.62 4.825
P/FCF -13.63 -10.75 -7.96 -8.16 -4.57 -4.18 -1.95 -1.72 27.70 33.26 -606.03 -65.67 -4.91 -3.69 -3.69 -2.50 -3.39 -4.68 -6.23 -4.08 -4.082
P/OCF 22.60 24.71 519.73
EV/EBITDA -7.84 -6.45 -4.54 -4.74 -1.75 -1.72 -0.34 -0.12 -2.24 -2.14 -9.40 -9.87 -1.59 -1.06 -1.02 -0.20 -1.72 -3.10 -5.14 -2.96 -2.957
EV/Revenue 6.50 9.10 6.17 7.20 2.93 2.90 0.79 0.30 6.13 4.89 14.09 15.35 2.71 2.38 3.05 0.52 5.95 15.36 39.26 108.10 108.104
EV/EBIT -7.24 -6.10 -4.31 -4.54 -1.69 -1.65 -0.33 -0.12 -2.21 -2.12 -9.33 -9.79 -1.58 -1.05 -1.01 -0.19 -1.70 -3.07 -5.11 -2.94 -2.945
EV/FCF -13.43 -10.61 -4.53 -5.05 -1.89 -1.74 -0.48 -0.19 19.38 22.60 -403.21 -46.09 -1.45 -0.92 -1.01 -0.19 -1.59 -3.04 -5.06 -3.03 -3.032
Earnings Yield -16.1% -18.2% -14.6% -14.8% -26.0% -26.5% -78.2% -93.0% -32.4% -32.7% -7.3% -7.2% -18.8% -23.8% -27.2% -38.8% -26.7% -20.6% -15.3% -24.5% -24.50%
FCF Yield -7.3% -9.3% -12.6% -12.3% -21.9% -23.9% -51.4% -58.2% 3.6% 3.0% -0.2% -1.5% -20.4% -27.1% -27.1% -40.0% -29.5% -21.4% -16.0% -24.5% -24.50%
PEG Ratio snapshot only 0.121
Price/Tangible Book snapshot only 3.621
EV/Gross Profit snapshot only 141.300
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 4.24 4.24 10.05 10.05 10.05 10.05 5.00 5.00 5.00 5.00 5.45 5.45 5.45 5.45 7.81 7.81 7.81 7.81 8.88 8.88 8.877
Quick Ratio 3.88 3.88 9.90 9.90 9.90 9.90 4.92 4.92 4.92 4.92 5.39 5.39 5.39 5.39 7.77 7.77 7.77 7.77 8.83 8.83 8.828
Debt/Equity 2.21 2.21 0.21 0.21 0.21 0.21 0.48 0.48 0.48 0.48 0.02 0.02 0.02 0.02 0.06 0.06 0.06 0.06 0.07 0.07 0.068
Net Debt/Equity -0.21 -0.21 -0.93 -0.93 -0.93 -0.93 -1.02 -1.02 -1.02 -1.02 -1.22 -1.22 -1.22 -1.22 -1.04 -1.04 -1.04 -1.04 -0.93 -0.93 -0.932
Debt/Assets 0.45 0.45 0.15 0.15 0.15 0.15 0.26 0.26 0.26 0.26 0.01 0.01 0.01 0.01 0.05 0.05 0.05 0.05 0.06 0.06 0.057
Debt/EBITDA -1.26 -0.89 -0.78 -0.66 -0.57 -0.55 -0.48 -0.47 -0.45 -0.48 -0.07 -0.06 -0.06 -0.05 -0.17 -0.15 -0.12 -0.10 -0.09 -0.07 -0.075
Net Debt/EBITDA 0.12 0.09 3.43 2.92 2.49 2.41 1.02 1.00 0.96 1.01 4.73 4.20 3.80 3.19 2.70 2.35 1.94 1.66 1.19 1.02 1.025
Interest Coverage -5.50 -8.17 -9.63 -11.55 -15.92 -19.61 -31.06 -35.50 -38.39 -48.38 -55.71 -180.22 -9340.43 -10737.07 -12980.00 -15149.36
Equity Multiplier 4.95 4.95 1.43 1.43 1.43 1.43 1.87 1.87 1.87 1.87 1.33 1.33 1.33 1.33 1.24 1.24 1.24 1.24 1.19 1.19 1.189
Cash Ratio snapshot only 8.267
Cash to Debt snapshot only 14.736
FCF to Debt snapshot only -13.072
Defensive Interval snapshot only 389.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.48 0.40 0.21 0.22 0.23 0.24 0.19 0.18 0.17 0.19 0.17 0.19 0.19 0.17 0.11 0.14 0.13 0.11 0.08 0.02 0.019
Inventory Turnover 2.05 2.03 1.83 1.91 1.87 1.78 2.56 2.21 2.23 2.17 1.36 1.40 1.28 1.15 1.20 1.21 0.81 0.81 1.00 0.87 0.869
Receivables Turnover 3.76 3.12 2.66 2.80 2.98 3.05 2.45 2.35 2.21 2.51 5.64 6.13 6.18 5.61 61.29 79.38 73.51 59.97 49.88 12.11 12.107
Payables Turnover 1.70 1.69 1.34 1.40 1.37 1.30 1.25 1.08 1.09 1.06 0.75 0.76 0.70 0.63 0.41 0.41 0.28 0.28 0.09 0.08 0.077
DSO 97 117 137 130 122 120 149 155 166 145 65 60 59 65 6 5 5 6 7 30 30.1 days
DIO 178 179 200 191 195 206 143 165 164 168 268 261 284 318 305 302 449 452 364 420 420.1 days
DPO 214 216 272 260 266 280 292 338 335 345 489 477 520 582 896 885 1319 1327 4117 4754 4754.3 days
Cash Conversion Cycle 61 80 65 61 52 45 0 -17 -6 -31 -157 -157 -177 -199 -585 -579 -864 -868 -3746 -4304 -4304.0 days
Fixed Asset Turnover snapshot only 0.377
Operating Cycle snapshot only 450.2 days
Cash Velocity snapshot only 0.025
Capital Intensity snapshot only 47.800
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 72.1% -9.5% 7.3% 13.5% 5.9% 30.4% 12.1% 2.3% -10.0% 0.3% 11.1% 25.7% 35.0% 7.5% -6.0% 12.0% 3.0% -7.4% -27.5% -86.4% -86.41%
Net Income 20.4% -35.0% -28.7% -50.8% -84.1% -43.7% -75.0% -52.6% -38.5% -28.0% 30.8% 23.0% 18.1% -3.4% -84.9% -86.0% -1.0% -98.7% -77.2% -85.0% -85.04%
EPS 65.4% 40.0% 42.9% -0.1% -41.8% -10.7% -53.2% -51.7% -37.6% -24.7% 38.7% 45.4% 42.1% 27.2% -20.7% -41.1% -53.7% -54.2% -37.8% -50.1% -50.11%
FCF 60.3% 12.8% -2.4% -3.1% -2.4% -1.5% -33.6% -15.7% 1.2% 1.1% 97.6% 74.0% -9.0% -13.8% -80.0% -8.1% -1.1% -81.0% -86.8% -79.5% -79.46%
EBITDA 23.6% -50.2% -41.4% -68.8% -1.1% -56.2% -92.3% -65.5% -47.2% -36.0% 28.6% 20.5% 15.8% -5.0% -87.3% -91.1% -1.1% -1.1% -85.4% -87.4% -87.38%
Op. Income 19.8% -49.0% -48.2% -70.3% -93.6% -48.0% -80.2% -64.3% -50.2% -38.5% 24.7% 15.6% 7.4% -14.2% -94.3% -85.8% -91.7% -86.7% -66.9% -74.6% -74.64%
OCF Growth snapshot only -80.56%
Asset Growth snapshot only -13.02%
Equity Growth snapshot only -9.03%
Debt Growth snapshot only -4.97%
Shares Change snapshot only 23.27%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.4% 1.2% 1.0% 90.2% 50.6% 44.1% 26.7% 15.5% 17.9% 5.8% 10.1% 13.4% 8.8% 12.0% 5.4% 12.9% 7.8% -0.1% -8.8% -42.4% -42.37%
Revenue 5Y 89.1% 86.8% 40.0% 40.4% 40.6% 40.9% 73.8% 68.3% 66.0% 69.2% 58.7% 54.6% 32.9% 26.4% 16.3% 16.7% 17.9% 3.3% -1.8% -26.0% -25.98%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 2.6% 58.7% 23.2% 13.2% 15.3% 4.3% 13.1% 17.3% 13.5% 18.8% 11.2% 19.9% 14.3% 4.9% -4.0% -43.7% -43.68%
Gross Profit 5Y 97.1% 1.3% 37.1% 17.5% 18.4% 20.3% 5.0% 0.5% -27.0% -26.97%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 8.6% 8.6% 54.3% 54.3% 54.3% 54.3% 35.2% 35.2% 35.2% 35.2% 57.0% 57.0% 57.0% 57.0% 16.7% 16.7% 16.7% 16.7% 26.4% 26.4% 26.37%
Assets 5Y 23.7% 23.7% 52.8% 52.8% 69.8% 69.8% 57.4% 57.4% 20.3% 20.3% 37.7% 37.7% 37.7% 37.7% 41.8% 41.8% 41.8% 41.8% 31.7% 31.7% 31.74%
Equity 3Y 16.6% 16.6% 1.5% 1.5% 1.5% 1.5% 1.3% 1.3% 1.3% 1.3% 1.4% 1.4% 1.4% 1.4% 22.2% 22.2% 22.2% 22.2% 47.0% 47.0% 47.00%
Book Value 3Y -32.6% -25.4% 66.1% 59.3% 65.0% 65.3% 48.9% 52.8% 56.6% 56.9% 70.3% 88.7% 98.0% 96.5% -2.6% -0.9% -0.9% -1.0% 12.6% 11.5% 11.46%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.82 0.80 0.80 0.83 0.89 0.87 0.95 0.91 0.83 0.82 0.88 0.90 0.80 0.90 0.85 0.97 0.89 0.64 0.00 0.05 0.055
Earnings Stability 0.31 0.21 0.26 0.21 0.32 0.22 0.32 0.25 0.34 0.19 0.03 0.03 0.34 0.80 0.64 0.76 0.76 0.82 0.76 0.76 0.763
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.48 0.86 0.93 0.93 0.92 0.94 0.93 0.92 0.919
Rev. Growth Consistency 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 1.00 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.92 0.86 0.89 0.50 0.50 0.83 0.50 0.50 0.85 0.89 0.88 0.91 0.93 0.99 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 4.12 1.96 4.32 3.88 3.84 3.47 0.32 0.32 0.23 0.64 0.42 0.42 0.43 0.34 0.27 0.24 0.19 0.10 -0.43 -0.52 -0.521
Gross Margin Trend 0.34 0.03 -0.07 -0.06 -0.04 -0.01 -0.01 0.02 0.00 0.04 0.11 0.11 0.11 0.09 0.07 0.07 0.09 0.07 0.03 -0.15 -0.154
FCF Margin Trend 2.76 1.57 0.25 -0.07 -0.26 -0.79 -0.73 -0.70 1.33 1.48 1.46 1.19 -1.26 -1.86 -2.18 -1.73 -2.96 -3.86 -6.24 -34.14 -34.142
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.45 0.51 0.86 0.82 0.83 0.88 0.64 0.60 -0.14 -0.12 -0.03 0.16 1.03 1.10 0.96 1.01 1.09 1.03 1.04 0.99 0.985
FCF/OCF 1.02 1.01 1.00 1.01 1.01 1.02 1.03 1.04 0.82 0.74 -0.86 1.34 1.05 1.04 1.03 1.02 1.02 1.01 1.01 1.01 1.015
FCF/Net Income snapshot only 1.000
CapEx/Revenue 0.9% 1.1% 0.4% 0.8% 1.2% 3.7% 5.2% 6.2% 7.1% 7.5% 7.6% 8.4% 9.3% 10.0% 9.4% 5.6% 6.7% 6.3% 10.5% 52.5% 52.54%
CapEx/Depreciation snapshot only 3.592
Accruals Ratio -0.28 -0.33 -0.05 -0.07 -0.07 -0.05 -0.17 -0.18 -0.54 -0.51 -0.27 -0.25 0.01 0.04 -0.01 0.00 0.04 0.01 0.02 -0.01 -0.010
Sloan Accruals snapshot only -0.112
Cash Flow Adequacy snapshot only -66.868
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 2.4% 1.8% 1.7% 2.6% 0.1% 0.2% 0.2% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -56.3% -44.5% -54.2% -22.3% -34.4% -36.5% 0.1% -0.2% -0.1% -3.7% -23.3% -21.2% -50.2% -53.6% -35.1% -43.6% -25.0% -16.0% -11.5% -15.8% -15.85%
Total Shareholder Return -56.3% -44.5% -54.2% -22.3% -34.4% -36.5% 0.1% -0.2% -0.1% -3.7% -23.3% -21.2% -50.2% -53.6% -35.1% -43.6% -25.0% -16.0% -11.5% -15.8% -15.85%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.001
Interest Burden (EBT/EBIT) 1.18 1.12 1.10 1.09 1.06 1.05 1.03 1.03 1.03 1.02 1.02 1.01 1.00 1.00 1.00 0.98 0.96 0.97 0.96 0.97 0.971
EBIT Margin -0.90 -1.49 -1.43 -1.59 -1.74 -1.75 -2.39 -2.50 -2.77 -2.31 -1.51 -1.57 -1.72 -2.26 -3.02 -2.68 -3.50 -5.01 -7.69 -36.71 -36.708
Asset Turnover 0.48 0.40 0.21 0.22 0.23 0.24 0.19 0.18 0.17 0.19 0.17 0.19 0.19 0.17 0.11 0.14 0.13 0.11 0.08 0.02 0.019
Equity Multiplier 6.13 6.13 1.75 1.75 1.75 1.75 1.58 1.58 1.58 1.58 1.48 1.48 1.48 1.48 1.28 1.28 1.28 1.28 1.22 1.22 1.218
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.45 $-1.89 $-1.79 $-1.80 $-2.05 $-2.10 $-2.74 $-2.73 $-2.82 $-2.61 $-1.68 $-1.49 $-1.63 $-1.90 $-2.03 $-2.10 $-2.51 $-2.93 $-2.79 $-3.16 $-3.16
Book Value/Share $0.65 $0.64 $5.64 $4.95 $4.94 $4.94 $2.58 $2.57 $2.56 $2.51 $6.32 $5.03 $5.01 $4.89 $5.21 $4.82 $4.81 $4.80 $3.69 $3.56 $2.68
Tangible Book/Share $-0.23 $-0.23 $4.94 $4.34 $4.33 $4.33 $2.58 $2.57 $2.56 $2.51 $6.32 $5.03 $5.01 $4.89 $5.21 $4.82 $4.81 $4.80 $3.69 $3.56 $3.56
Revenue/Share $1.36 $1.13 $1.13 $1.04 $1.11 $1.14 $1.11 $1.06 $0.99 $1.11 $1.09 $0.95 $0.95 $0.84 $0.67 $0.80 $0.74 $0.60 $0.38 $0.09 $0.09
FCF/Share $-0.66 $-0.97 $-1.54 $-1.49 $-1.72 $-1.89 $-1.80 $-1.71 $0.31 $0.24 $-0.04 $-0.31 $-1.77 $-2.17 $-2.02 $-2.17 $-2.77 $-3.04 $-2.93 $-3.16 $-3.16
OCF/Share $-0.65 $-0.96 $-1.53 $-1.48 $-1.71 $-1.85 $-1.74 $-1.65 $0.38 $0.32 $0.04 $-0.24 $-1.69 $-2.08 $-1.96 $-2.12 $-2.73 $-3.01 $-2.89 $-3.11 $-3.11
Cash/Share $1.56 $1.56 $6.47 $5.68 $5.67 $5.67 $3.87 $3.86 $3.85 $3.77 $7.85 $6.26 $6.22 $6.08 $5.75 $5.32 $5.30 $5.29 $3.69 $3.56 $2.59
EBITDA/Share $-1.13 $-1.59 $-1.54 $-1.59 $-1.86 $-1.92 $-2.59 $-2.61 $-2.71 $-2.54 $-1.64 $-1.47 $-1.61 $-1.88 $-2.00 $-2.13 $-2.57 $-2.99 $-2.88 $-3.24 $-3.24
Debt/Share $1.43 $1.43 $1.20 $1.05 $1.05 $1.05 $1.24 $1.24 $1.23 $1.21 $0.12 $0.09 $0.09 $0.09 $0.34 $0.31 $0.31 $0.31 $0.25 $0.24 $0.24
Net Debt/Share $-0.14 $-0.14 $-5.27 $-4.63 $-4.62 $-4.62 $-2.63 $-2.62 $-2.61 $-2.56 $-7.73 $-6.16 $-6.13 $-5.99 $-5.41 $-5.00 $-4.99 $-4.97 $-3.44 $-3.32 $-3.32
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 5.689
Altman Z-Prime snapshot only 10.308
Piotroski F-Score 5 3 5 4 5 5 2 3 3 4 6 5 4 4 4 4 3 2 1 2 2
Beneish M-Score -3.06 -4.01 -2.00 -2.05 -2.09 -1.96 -4.08 -4.32 -6.28 -5.84 -4.14 -3.76 -3.32 -3.64 10.49 11.32 10.76 16.21 13.02 26.20 26.205
Ohlson O-Score snapshot only 1.146
ROIC (Greenblatt) snapshot only -89.63%
Net-Net WC snapshot only $3.15
EVA snapshot only $-224720070.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 23.72 23.97 34.24 35.44 29.99 30.40 31.92 31.54 39.30 38.19 69.81 65.32 49.51 49.78 38.41 32.67 42.94 61.54 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only 42.942
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms